Table 2 Univariate analysis (group 2) for use of temporary pacing according to demographic, and preoperative variables a
From: Predictors of temporary epicardial pacing wires use after valve surgery
Variable | Temporary cardiac pacing | ||
|---|---|---|---|
| Â | No | Yes | p-value |
Age (year) | Â | Â | 0.013 |
  < 40 | 13 (81.3) | 3 (18.8) |  |
  40–59 | 84 (84.8) | 15 (15.20) |  |
  ≥ 60 | 78 (67.8) | 37 (32.2) |  |
Sex | Â | Â | Â |
  Female | 79 (72.5) | 30 (27.5) | 0.223 |
  Male | 96 (79.3) | 25 (20.7) |  |
Renal failure (creatinine > 1.5 mg/dl) |  |  | 0.991 |
  No | 159 (76.1) | 50 (23.9) |  |
  Yes | 16 (76.2) | 5 (23.8) |  |
Diabetes mellitus | Â | Â | 0.001 |
  No | 119 (70.4) | 50 (29.6) |  |
  Yes | 56 (91.8) | 5 (8.2) |  |
COPD | Â | Â | 0.504 |
  No | 161 (76.7) | 49 (23.3) |  |
  Yes | 14 (70.0) | 6 (30.0) |  |
History of arrhythmia | Â | Â | 0.818 |
  No | 144 (75.8) | 46 (24.2) |  |
  Yes | 31 (77.5) | 9 (22.5) |  |
NYHA class | Â | Â | 0.000 |
  I-II | 136 (90.1) | 15 (9.9) |  |
  III-IV | 39 (49.4) | 40 (50.6) |  |
Left Ventricle ejection fraction (%) | Â | Â | 0.001 |
  > 35 | 114 (83.8) | 22 (16.2) |  |
  ≤ 35 | 61 (64.9) | 33 (35.1) |  |
PAP (mmHg) | Â | Â | 0.000 |
  < 50 | 171 (85.1) | 30 (14.9) |  |
  ≥ 50 | 4 (13.8) | 25 (86.2) |  |
Left atrium diameter (mm) | Â | Â | 0.104 |
  < 5.2 | 155 (77.9) | 44 (22.1) |  |
  ≥ 5.2 | 20 (64.5) | 11 (35.5) |  |
Beta blockers | Â | Â | 0.002 |
  No | 119 (70.8) | 49 (29.2) |  |
  Yes | 56 (90.3) | 6 (9.70) |  |
Digoxin | Â | Â | 0.440 |
  No | 159 (76.8) | 48 (23.2) |  |
  Yes | 16 (69.6) | 7 (30.4) |  |
Amiodarone | Â | Â | 0.011 |
  No | 167 (78.0) | 47 (22.0) |  |
  Yes | 8 (50.0) | 8 (50.0) |  |